Institutional investors purchased a net $1.1 million shares of EBS during the quarter ended December 2013. This may signal that the smart money is gaining interest in this company as the 69.39% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
REGIONS INVESTMENT MANAGEMENT, I... Bought 39.8 Thousand shares of Emergent BioSolutions Inc
TEACHERS RETIREMENT SYSTEM OF TH... Bought 5.1 Thousand shares of Emergent BioSolutions Inc